FDA sticking to its guns on NMN in dietary supplements
FDA is holding firm to its position expressed in the fall of 2022 that a healthy aging ingredient cannot be lawfully marketed in dietary supplement products.
Source: naturalproductsinsider.com
Stay updated with breaking news from Cellmark United. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA is holding firm to its position expressed in the fall of 2022 that a healthy aging ingredient cannot be lawfully marketed in dietary supplement products.